Issues & Opinions
Duchenne muscular dystrophy: Drug development and regulatory considerations
Article first published online: 5 APR 2010
Copyright © 2010 Wiley Periodicals, Inc.
Muscle & Nerve
Volume 41, Issue 6, pages 740–745, June 2010
How to Cite
McNeil, D. E., Davis, C., Jillapalli, D., Targum, S., Durmowicz, A. and Coté, T. R. (2010), Duchenne muscular dystrophy: Drug development and regulatory considerations. Muscle Nerve, 41: 740–745. doi: 10.1002/mus.21623
- Issue published online: 25 MAY 2010
- Article first published online: 5 APR 2010
- Manuscript Accepted: 11 NOV 2009
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!